Price (delayed)
$1.54
Market cap
$1.05B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.18
Enterprise value
$1.15B
Opko Health Inc. is a multinational biopharmaceutical and diagnostics company that seeks to establish industry-leading positions in large, rapidly growing markets by leveraging its discovery, development, and commercialization expertise and
There are no recent dividends present for OPK.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.